Ticker Details
Zentalis Pharmaceuticals, Inc.
IPO Date:	April 3, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$362.12M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.79 | 3.83%
Avg Daily Range (30 D):	$0.23 | 4.94%
Avg Daily Range (90 D):	$0.20 | 4.52%

Institutional Daily Volume
Avg Daily Volume:	.71M
Avg Daily Volume (30 D):	1.14M
Avg Daily Volume (90 D):	1.09M

Trade Size
Avg Trade Size (Sh.):	98
Avg Trade Size (Sh.) (30 D):	104
Avg Trade Size (Sh.) (90 D):	103

Institutional Trades
Total Institutional Trades:	1,946
Avg Institutional Trade:	$2.09M
Avg Institutional Trade (30 D):	$.79M
Avg Institutional Trade (90 D):	$1.67M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.74M
Avg Closing Trade (30 D):	$.88M
Avg Closing Trade (90 D):	$2.6M
Avg Closing Volume:	126.76K

News

Jul 3, 2026 @ 1:58 PM Osteosarcoma Therapeutics Pipeline 2026: Explore 2... Source: Researchandmarkets.Com

Jun 1, 2026 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Na

May 1, 2026 @ 9:30 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Na

Apr 1, 2026 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Na

Jan 12, 2026 @ 3:35 PM Fast-Tracking the $537B Cancer Cure: How Accelerat... Source: Prnewswire

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.96	$-.59	$-.5
Diluted EPS	$-1.96	$-.59	$-.5
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-139.55M	$-42.29M	$-35.35M
Operating Income / Loss	$-153.37M	$-44.39M	$-37.86M
Cost of Revenue
Net Cash Flow	$-12.82M	$-7.15M	$-4.07M
PE Ratio